History of antibiotics. From salvarsan to cephalosporins.
about
Adapting Drug Approval Pathways for Bacteriophage-Based TherapeuticsStructure of a class III engineered cephalosporin acylase: comparisons with class I acylase and implications for differences in substrate specificity and catalytic activityCost-effectiveness and pricing of antibacterial drugs.New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.How to measure the impacts of antibiotic resistance and antibiotic development on empiric therapy: new composite indices.Autophagy as a target for therapeutic uses of multifunctional peptides.Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes.Antimicrobial peptides as natural bio-preservative to enhance the shelf-life of food.Evaluation of free or anchored antimicrobial peptides as candidates for the prevention of orthopaedic device-related infections.Specific disulfide cross-linking to constrict the mobile carrier domain of nonribosomal peptide synthetases.Antibiotics, gut microbiome, and obesity.History of antibiotics: from fluoroquinolones to daptomycin (Part 2).Stability of ceftiofur sodium and cefquinome sulphate in intravenous solutions.Systematic detection of positive selection in the human-pathogen interactome and lasting effects on infectious disease susceptibility.Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis
P2860
Q26740597-01B4C3C7-1814-4A74-B3BE-F9AC9078EF50Q27683865-07060763-A25A-4C5D-B228-85782E8F8536Q35084162-13B6B98C-9482-45B9-8CA3-5F750CE643BDQ36153263-29C3C8A9-2D37-48E3-B9B2-B7E5C1118FF3Q37517286-0B9810FC-49D6-462C-BAA9-C9DEE0923E8DQ38770314-A6B443B2-6BA0-4958-9ADB-584FE271E598Q38987535-FD7737ED-1D4A-4071-B822-D2F72A715816Q38989893-FFD7B973-B43C-4507-AA2D-0CD3F12685A7Q40134888-763D82B0-3372-4CF5-B9E3-FBE92FDBA474Q41589017-ADC9B96D-FB22-4CF6-9136-9016F0DED688Q41986554-65E877A5-C6F0-403E-9DA5-951DFA9B712BQ48202873-40208DDB-E82C-4820-904E-D2255637933BQ55006206-EFC75831-5EA7-4B89-A8AA-DEF583A8B4FCQ55082178-8B1B90CD-5B53-4A01-B486-5E8DC80CFFEEQ57295053-64ABC489-0E4E-45C8-94E8-056AB30CE08F
P2860
History of antibiotics. From salvarsan to cephalosporins.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
History of antibiotics. From salvarsan to cephalosporins.
@ast
History of antibiotics. From salvarsan to cephalosporins.
@en
History of antibiotics. From salvarsan to cephalosporins.
@nl
type
label
History of antibiotics. From salvarsan to cephalosporins.
@ast
History of antibiotics. From salvarsan to cephalosporins.
@en
History of antibiotics. From salvarsan to cephalosporins.
@nl
prefLabel
History of antibiotics. From salvarsan to cephalosporins.
@ast
History of antibiotics. From salvarsan to cephalosporins.
@en
History of antibiotics. From salvarsan to cephalosporins.
@nl
P2093
P2860
P1476
History of antibiotics. From salvarsan to cephalosporins.
@en
P2093
Jared Gardner
Lorenzo Zaffiri
Luis H Toledo-Pereyra
P2860
P356
10.3109/08941939.2012.664099
P577
2012-04-01T00:00:00Z